Also, I am shocked that the world of telemedicine, telehealth companies, the likes of pharma (obviously Pfizer excepted) and multinational computer behemoths like Apple and Microsoft at the end weren't motivated enough to mount an alternative offer. I am genuinly surprised that such a disruptive yet simple concept was largely ignored by people that I thought would have jumped on it.
And how must Professor Abeyratne feel that the company has been sold. Perhaps Pfizer will continue to use him and his team for further inroads into respiratory identification.
Anyway, on to the next big thing....
RAP Price at posting:
21.0¢ Sentiment: None Disclosure: Not Held
